La cadena de opciones muestra datos clave de las opciones de acciones de Gentherm a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Gentherm..

Gentherm (NASDAQ:THRM) Bolsa, Cadena de Opciones

Gentherm

Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.

Gentherm Inc

Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Gentherm to report an earnings per share (EPS) of $0.66.
Anticipation surrounds Gentherm's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
The company's EPS beat by $0.05 in the last quarter, leading to a 1.96% drop in the share price on the following day.
Here's a look at Gentherm's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.61</td>
<td>0.43</td>
<td>0.52</td>
<td>0.68</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.66</td>
<td>0.62</td>
<td>0.90</td>
<td>0.64</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>3.0%</td>
<td>-1.0%</td>
<td>-8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730228486_0.png" alt="eps graph" />
<h3>Performance of Gentherm Shares</h3>
Shares of Gentherm were trading at $41.7 as of October 28. Over the last 52-week period, shares are up 5.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on Gentherm</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Gentherm.
Analysts have given Gentherm a total of 1 ratings, with the consensus rating being Neutral. The average one-year price target is $56.0, indicating a potential 34.29% upside.
<h3>Peer Ratings Comparison</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of XPEL, Dana and Fox Factory Hldg, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for XPEL, with an average 1-year price target of $58.0, suggesting a potential 39.09% upside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Dana, with an average 1-year price target of $13.33, implying a potential 68.03% downside.</li>
<li>As per analysts' assessments, Fox Factory Hldg is favoring an Neutral trajectory, with an average 1-year price target of $46.75, suggesting a potential 12.11% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary offers a detailed examination of key metrics for XPEL, Dana and Fox Factory Hldg, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gentherm</td>
<td>Neutral</td>
<td>0.90%</td>
<td>$96.70M</td>
<td>2.93%</td>
</tr>
<tr>
<td>XPEL</td>
<td>Buy</td>
<td>7.51%</td>
<td>$47.87M</td>
<td>7.74%</td>
</tr>
<tr>
<td>Dana</td>
<td>Neutral</td>
<td>-0.36%</td>
<td>$255M</td>
<td>1.06%</td>
</tr>
<tr>
<td>Fox Factory Hldg</td>
<td>Neutral</td>
<td>-13.03%</td>
<td>$110.96M</td>
<td>0.45%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Gentherm is positioned in the middle among its peers for revenue growth, with one peer showing the highest growth rate. In terms of gross profit, Gentherm ranks second highest. However, Gentherm has the highest return on equity compared to its peers.
<h3>About Gentherm</h3>
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
<h3>Breaking Down Gentherm's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Gentherm showcased positive performance, achieving a revenue growth rate of 0.9% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Gentherm's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 5.02%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Gentherm's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.93%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Gentherm's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.51%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Gentherm's debt-to-equity ratio is below the industry average at 0.39, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/THRM/earnings">To track all earnings releases for Gentherm visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

THRM

Earnings Preview: Gentherm

JP Morgan analyst Ryan Brinkman upgrades Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) from Underweight to Neutral and maintains the price target from $56 to $56.

News

Upgrades

Price Target

Analyst Ratings

JP Morgan Upgrades Gentherm to Neutral, Maintains Price Target to $56

Effective September 1, 2024; Anversa To Join Logitech International As CFO

Management

LOGI

Gentherm Announces Resignation Of CFO Matteo Anversa

Guidance
The Company&#39;s full-year 2024&nbsp;guidance&nbsp;as of July 31, 2024 is shown below:
<table align="center">
<tbody>
<tr>
<td>Initial 2024&nbsp;Guidance</td>
<td>Latest Estimate(1)</td>
</tr>
<tr>
<td>Product Revenues</td>
<td>$1.5B&nbsp;&ndash;&nbsp;$1.6B</td>
<td>Low end of range</td>
</tr>
<tr>
<td>Adjusted EBITDA Margin Rate</td>
<td>12.5%&nbsp;&ndash;&nbsp;13.5%</td>
<td>Above mid-point of range</td>
</tr>
<tr>
<td>Full-year Adjusted Effective Tax Rate</td>
<td>26%&nbsp;&ndash;&nbsp;29%</td>
<td>No change</td>
</tr>
<tr>
<td>Capital Expenditures</td>
<td>$65M&nbsp;&ndash;&nbsp;$75M</td>
<td>No change</td>
</tr>
<tr>
		</tr>
<tr>
<td colspan="4">(1) Based on the current forecast of customer orders, and light vehicle production in the Company&#39;s key markets declining at a low single digit rate in 2024 versus 2023, and a EUR to USD exchange rate of&nbsp;$1.08/Euro for the remainder of the year.</td>
</tr>
</tbody>
</table>

Guidance

Gentherm 2024 Outlook: Sees Revenue Of $1.5b-$1.6b Vs. $1.527b Est.; And Adjusted EBITDA Margin Of 12.5%-13.5%

Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.61 by 8.2 percent. This is a 13.79 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $375.683 million which beat the analyst consensus estimate of $374.152 million by 0.41 percent. This is a 0.90 percent increase over sales of $372.323 million the same period last year.

Earnings Beats

Gentherm Q2 2024 Adj. EPS $0.66 Beats $0.61 Estimate, Sales $375.683M Beat $374.152M Estimate

JP Morgan analyst Ryan Brinkman maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Underweight and lowers the price target from $60 to $56.

JP Morgan Maintains Underweight on Gentherm, Lowers Price Target to $56

Baird analyst Luke Junk maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $65 to $60.

Baird Maintains Neutral on Gentherm, Lowers Price Target to $60

Cognizant Technology Solutions (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctsh#NASDAQ">CTSH</a>) benefits from an expanding portfolio with the recent launch of Neuro Edge, a new platform in its Neuro suite.
The solution empowers businesses across industries to harness the power of edge AI, enabling real-time decision-making and operational efficiency while reducing dependency on centralized servers and the cloud.
Neuro Edge supports a hybrid Cloud + Edge AI approach, ensuring data privacy, security and seamless integration with existing IT environments.
With applications spanning healthcare, manufacturing, retail, automotive and more, Cognizant is poised to transform enterprise capabilities in AI-driven edge computing.
<h3>Cognizant&#39;s Prospects Driven by Strong Partner Base</h3>
The latest move bodes well with CTSH&#39;s focus on enhancing AI capabilities and providing industry-specific solutions through the Cognizant Neuro Edge platform.
Further expanding its portfolio, Cognizant recently announced an agreement with Texas Dow Employees Credit Union (TDECU) to leverage its AI-driven Neuro IT Operations platform for enhancing operational efficiency, resilience and customer experience in TDECU&#39;s transformation journey.
Cognizant&#39;s robust partner base, which includes the likes of Gentherm (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>), Microsoft&nbsp;and CNO Financial Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cno#NYSE">CNO</a>), is a critical catalyst. Its robust pipeline, which includes a favorable mix of new opportunities, is noteworthy.
In first-quarter 2024, CTSH demonstrated significant improvement in securing large deals, winning several contracts worth more than $100 million each.
The company recently collaborated with Gentherm to provide engineering services, including systems engineering, validation and model-based development, aiming to enhance agility and scalability in product development through cloud-native technologies and virtualization.
In April, Cognizant, in collaboration with Microsoft, announced an expanded partnership aiming to leverage generative AI and Copilots to drive innovation across industries, focusing on transforming enterprise operations and enhancing employee experiences.
In first-quarter 2024 Cognizant announced the continuation of its partnership with CNO Financial, a leading provider of insurance, financial services, and workforce benefits solutions to middle-income America. Cognizant will help in optimizing and enhancing CNO Financials&#39; technology-based services and solutions with cloud and digital technologies.
<h3>Conclusion</h3>
Despite an expanding portfolio and a strong partner base, weakness in the Financial Services segment negatively impacted Cognizant&#39;s top line.
In first-quarter 2024, revenues of $4.76 billion saw a year-over-year decline of 1.1% and 1.2% at constant currency (cc). The Financial Services revenues dropped 6.2% year over year to $1.38 billion during this period.
The company&#39;s shares have declined 10.3% against the Zacks Computer &amp; Technology sector&#39;s growth of 24.5% year to date.
This Zacks Rank #2 (Buy) company expects second-quarter 2024 revenues to be between $4.75 billion and $4.82 billion, indicating a decline of 2.9% to 1.4% (a decline of 2.5-1% at cc).
The Zacks Consensus Estimate for second-quarter revenues is pegged at $4.81 billion, indicating a decline of 1.63% from year-ago levels.
The consensus mark for earnings is pegged at $1.12 per share, unchanged in the past 30 days.
<a href="https://www.zacks.com/stock/news/2296262/cognizant-ctsh-expands-neuro-suite-with-edge-ai-platform?cid=CS-BENZ-FT-analyst_blog|company_news_tech_sector-2296262">To read this article on Zacks.com click here.</a>

Small Cap

Markets

Tech

Trading Ideas

CTSH

Cognizant Expands Neuro Suite With Edge AI Platform

Agreement expected to help develop next generation of innovative products, elevate customer vehicle experiences, and improve everyday life
TEANECK, N.J., June 17, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4191420-1&amp;h=3144140095&amp;u=https%3A%2F%2Fwww.cognizant.com%2Fus%2Fen&amp;a=Cognizant">Cognizant</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>) today announced an agreement to provide engineering services to Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Cognizant is providing systems engineering, validation, and model-based development services from Hyderabad, India, and has created a test facility to conduct research and development for Gentherm products.

Cognizant, Gentherm Sign Agreement For Strategic Product Engineering Services And Development Of A New Delivery Center

Buybacks

Gentherm Announces $150M Stock Repurchase Program Authorized By Board Of Directors

Baird analyst Luke Junk maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Neutral and lowers the price target from $67 to $65.

Baird Maintains Neutral on Gentherm, Lowers Price Target to $65

WIIM

Gentherm shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued guidance.

Gentherm Sees FY24 Revenue Of $1.5B - $1.6B Vs. $1.55B Est.

Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.43 by 44.19 percent. This is a 26.53 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $356.01 million which missed the analyst consensus estimate of $358.53 million by 0.70 percent. This is a 2.09 percent decrease over sales of $363.63 million the same period last year.

Earnings Misses

Gentherm Q1 Adj $0.62 Beats $0.43 Estimate, Sales $356.01M Miss $358.53M Estimate

Analysts' ratings for Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $61.75, a high estimate of $66.00, and a low estimate of $58.00. This current average reflects an increase of 2.92% from the previous average price target of $60.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1713798044_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Gentherm among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$60.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$63.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Luke Junk</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ryan Brinkman</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Gentherm. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Gentherm compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Gentherm's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Gentherm's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/THRM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Gentherm analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Gentherm</h2>
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
<h3>Financial Insights: Gentherm</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Gentherm displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 6.88%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 4.93%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Gentherm's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.77%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Gentherm's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.47%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.38, Gentherm adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 4 Analyst Recommendations For Gentherm

JP Morgan analyst Ryan Brinkman maintains Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) with a Underweight and lowers the price target from $63 to $60.

JP Morgan Maintains Underweight on Gentherm, Lowers Price Target to $60

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 150 points on Wednesday.
The Dow traded down 0.39% to 38,412.53 while the NASDAQ fell 1.06% to 15,464.67. The S&amp;P 500 also fell, dropping, 0.47% to 4,952.19.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.7% on Wednesday.
In trading on Wednesday, information technology shares fell by 1.7%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The minutes from the latest Federal Open Market Committee (FOMC) meeting underscored the Federal Reserve&rsquo;s commitment to await more concrete evidence of a disinflationary trend before contemplating interest rate reductions.
According to the Fed statement, the FOMC emphasized that it anticipates maintaining interest rates steady &ldquo;until it has gained greater confidence that inflation is moving sustainably toward 2%.&rdquo;
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) shares shot up 23% to $19.43 after the company reported better-than-expected fourth-quarter financial results.
Shares of Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) got a boost, surging 20% to $58.91 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 64% to $1.0701 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 28% to $263.05 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 26% to $0.0758 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 27% to $2.9350 after the company reported fourth-quarter financial results.
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 1.2% to $77.94 while gold traded down 0.2% at $2,035.50.
Silver traded down 0.9% to $22.925 on Wednesday while copper rose 0.2% to $3.8745.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.17%, London&rsquo;s FTSE 100 fell 0.73% while Spain&rsquo;s IBEX 35 Index rose 0.69% The German DAX gained 0.29% French CAC 40 rose 0.22% while Italy&rsquo;s FTSE MIB Index rose 1.00%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

MOTS

PANW

UCAR

Nasdaq Down 1%; Gentherm Shares Spike Higher

Shares of International Flavors &amp; Fragrances Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iff#NYSE">IFF</a>) fell during Wednesday&rsquo;s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.
International Flavors &amp; Fragrances shares dipped 8.4% to $75.11 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Greenbrook TMS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbnh#NASDAQ">GBNH</a>) climbed 120.8% to $0.4351. Greenbrook TMS raised $2.5 million in debt financing.</li>
<li>Emergent BioSolutions Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ebs#NYSE">EBS</a>) gained 84% to $2.8050. Emergent BioSolutions appointed Joseph Papa as President and CEO, effective Feb. 21, 2024.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) gained 77.2% to $5.30. Traders circulated unconfirmed analyst comments suggesting co might be the next big weight loss drug citing a new publication showing NLRP3 has significant weight loss similar to GLP-1.</li>
<li>Sound Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sogp#NASDAQ">SOGP</a>) shares rose 63.1% to $4.60. Sound Group announced the launch of new AI-powered applications.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares rose 59.4% to $1.04 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;</li>
<li>Origin Agritech Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seed#NASDAQ">SEED</a>) gained 34% to $3.11. Origin Agritech increased revenue by 77% year-over-year for the fiscal year ended Sep. 30, 2023.</li>
<li>Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) shares jumped 24.7% to $61.48 after the company reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>RAPT Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rapt#NASDAQ">RAPT</a>) gained 24% to $8.52.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) shares jumped 23.4% to $1.7050.</li>
<li>MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) rose 19% to $18.80 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Janux Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/janx#NASDAQ">JANX</a>) gained 18% to $11.75. Janux Therapeutics will host virtual event on Feb. 26th, 2024, at 4:30PM ET to discuss updated clinical data for PSMA-TRACTr JANX007 and EGFR-TRACTr JANX008.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) rose 15.9% to $13.95.</li>
<li>TPG RE Finance Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trtx#NYSE">TRTX</a>) jumped 12.9% to $6.24 after the company reported fourth-quarter financial results.</li>
<li>Garmin Ltd.(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/grmn#NYSE">GRMN</a>) rose 12.2% to $137.72 after the company reported fourth-quarter financial results and issued FY24 revenue guidance above estimates, recommended boosting annual dividend and authorized share buyback.</li>
<li>Select Water Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wttr#NYSE">WTTR</a>) gained 11.7% to $8.77 following strong earnings.</li>
<li>The Hackett Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hckt#NASDAQ">HCKT</a>) surged 11.2% to $25.48 following upbeat results.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) jumped 8.8% to $57.28 following upbeat earnings.</li>
<li>EQT Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eqt#NYSE">EQT</a>) gained 8.8% to $36.69.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.6% to $136.15 following fourth-quarter results.</li>
<li>Bausch + Lomb Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blco#NYSE">BLCO</a>) gained 8.6% to $15.84 after reporting quarterly results.</li>
<li>Wix.com Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wix#NASDAQ">WIX</a>) gained 8.2% to $135.56 following fourth-quarter results.</li>
<li>NeoGenomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neo#NASDAQ">NEO</a>) rose 7.4% to $15.78 after the company reported better-than-expected fourth-quarter financial results and issued FY24 adjusted EPS guidance above estimates.</li>
<li>Toll Brothers, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tol#NYSE">TOL</a>) gained 6.6% to $110.42 after the company reported better-than-expected first-quarter financial results and issued FY24 EPS guidance above estimates.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>AtlasClear Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atch#NYSE">ATCH</a>) shares tumbled 41% to $1.19.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) dipped 33.4% to $1.53 after gaining around 56% on Tuesday.</li>
<li>Synchronoss Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sncr#NASDAQ">SNCR</a>) fell 32.2% to $8.30.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) dipped 30% to $0.0710 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.</li>
<li>MoneyHero Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mny#NASDAQ">MNY</a>) fell 28% to $2.2259.</li>
<li>Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) fell 27.3% to $2.9350 after the company reported fourth-quarter financial results.</li>
<li>Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dipped 26.2% to $270.29 after the company issued third-quarter guidance below estimates.</li>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) shares fell 25.3% to $15.31 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>Unisys Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uis#NYSE">UIS</a>) fell 24.5% to $5.88 after the company reported quarterly financial results.</li>
<li>Pop Culture Group Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpop#NASDAQ">CPOP</a>) fell 21.3% to $5.66 after jumping 171% on Tuesday.</li>
<li>Amplitude, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampl#NASDAQ">AMPL</a>) fell 16.6% to $11.73 after the company reported mixed fourth-quarter financial results and issued weak guidance.</li>
<li>SolarEdge Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>) shares fell 15.7% to $71.20 after the company reported mixed fourth-quarter financial results.</li>
<li>Matterport, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mttr#NASDAQ">MTTR</a>) shares fell 15.4% to $2.1450 after the company posted weak quarterly sales and issued downbeat forecast.</li>
<li>Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) fell 14.8% to $212.15.</li>
<li>Medifast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/med#NYSE">MED</a>) declined 14.3% to $41.95 after the company issued weak guidance.</li>
<li>Avinger, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avgr#NASDAQ">AVGR</a>) shares fell 14.3% to $4.57 after surging 83% on Tuesday.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) fell 13% to $27.17 after the company reported first-quarter financial results below estimates.</li>
<li>Workiva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wk#NYSE">WK</a>) fell 12.3% to $82.55 following quarterly results.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) fell 11.4% to $0.5582.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) shares fell 6.1% to $1.0794. Biofrontera shares jumped 53% on Tuesday after the company announced a private placement of up to $16 million priced at the market per Nasdaq rules.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) shares declined 5.4% to $61.01 after the company reported fourth-quarter financial results and issued guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37237721/bitcoin-falls-below-51-000-starknet-becomes-top-loser"> Bitcoin Falls Below $51,000; Starknet Becomes Top Loser</a>

Movers

AMPL

ATCH

AVGR

BFRI

BLCO

CPOP

EFOI

GBNH

GRMN

HCKT

IOVA

JANX

LIVN

MTTR

PLAB

RAPT

SEDG

SEED

SISI

SNCR

SOGP

TDOC

TRTX

VTYX

WTTR

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Sonder Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) shares increased by 23.0% to $3.74 during Wednesday's regular session. The market value of their outstanding shares is at $41.3 million. </li>
<li>Gentherm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRM#NASDAQ">THRM</a>) shares rose 20.44% to $59.38. The market value of their outstanding shares is at $1.9 billion. The company's, Q4 earnings came out today. </li>
<li>Fossil Group, Inc. - 7% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSLL#NASDAQ">FOSLL</a>) stock rose 15.92% to $12.3. </li>
<li>Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) stock moved upwards by 11.97% to $1.59. The company's market cap stands at $214.2 million. </li>
<li>Lead Real Estate Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRE#NASDAQ">LRE</a>) stock rose 9.75% to $4.5. The market value of their outstanding shares is at $61.3 million. </li>
<li>Phinia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHIN#NYSE">PHIN</a>) stock moved upwards by 9.75% to $34.53. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q4 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) stock decreased by 29.2% to $0.07 during Wednesday's regular session. The market value of their outstanding shares is at $4.5 million. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock decreased by 21.15% to $1.79. The market value of their outstanding shares is at $2.1 million. </li>
<li>Global E Online (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBE#NASDAQ">GLBE</a>) stock decreased by 15.18% to $34.19. The market value of their outstanding shares is at $5.6 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Tarena International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCTM#NASDAQ">TCTM</a>) shares declined by 14.29% to $1.56. The market value of their outstanding shares is at $16.7 million. </li>
<li>Fisker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSR#NYSE">FSR</a>) stock fell 10.96% to $0.56. The company's market cap stands at $300.2 million. </li>
<li>Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) shares declined by 10.94% to $2.77. The market value of their outstanding shares is at $33.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BRLT

CANG

Fossil Group, Inc. - 7% Senior Notes due 2026

FOSLL

GLBE

JFBR

PHIN

SOND

TCTM

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.5% on Wednesday.
The Dow traded down 0.16% to 38,503.94 while the NASDAQ fell 0.47% to 15,557.94. The S&amp;P 500 also fell, dropping, 0.11% to 4,969.94.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37210537/top-4-tech-stocks-that-may-crash-this-month"> Top 4 Tech Stocks That May Crash This Month</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares rose by 1.5% on Wednesday.
In trading on Wednesday, information technology shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Exelon Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>) reported better-than-expected fourth-quarter financial results and increased its quarterly dividend.
Exelon reported fourth-quarter fiscal 2023 operating revenue growth of 15% year-over-year to $5.37 billion, beating the estimates of $4.17 billion. Adjusted EPS improved to 60 cents from 43 cents in 2022, beating the estimate of 58 cents.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
MediaAlpha, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/max#NYSE">MAX</a>) shares shot up 18% to $18.71 after the company reported better-than-expected fourth-quarter financial results.
Shares of Gentherm Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thrm#NASDAQ">THRM</a>) got a boost, surging 23% to $60.65 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares were also up, gaining 58% to $1.0326 after the company was granted U.S. Patent #11904085 for &#39;Systems And Methods For Cleaning A Colon.&#39;
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Palo Alto Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/panw#NASDAQ">PANW</a>) shares dropped 27% to $268.49 after the company issued third-quarter adjusted EPS and total revenue guidance below estimates.
Shares of U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) were down 30% to $0.0716 after the company received a delisting notice from the Nasdaq Stock Market due to its ordinary shares&rsquo; closing bid price falling below $0.10 for ten consecutive trading days, as per the Low Priced Stocks Rule.
Community Health Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cyh#NYSE">CYH</a>) was down, falling 26% to $2.97 after the company reported fourth-quarter financial results.
Also Check This Out:<a href="https://www.benzinga.com/news/24/02/37210908/alaska-air-to-rally-around-36-here-are-10-top-analyst-forecasts-for-tuesday"> Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.6% to $77.52 while gold traded down 0.3% at $2,034.40.
Silver traded down 1.1% to $22.88 on Wednesday while copper rose 0.1% to $3.8730.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 fell 0.22%, London&rsquo;s FTSE 100 fell 0.75% while Spain&rsquo;s IBEX 35 Index rose 0.67% The German DAX gained 0.22% French CAC 40 rose 0.17% while Italy&rsquo;s FTSE MIB Index rose 1%.
The Confederation of British Industry survey&#39;s total order book balance climbed by 10 points to a reading of -20 in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index rising 1.57%, China&rsquo;s Shanghai Composite Index gaining 0.97% and India&rsquo;s S&amp;P BSE Sensex falling 0.59%.
Japanese trade deficit narrowed to JPY 1,758.311 billion in January from JPY 3,506.43 billion in the year-ago month. Exports from Japan surged by 11.9% year-over-year, while imports to Japan dipped 9.6% year-over-year.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications fell by 10.6% on the week ending Feb. 16, 2024.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37209778/starbucks-regeneron-pharmaceuticals-and-2-other-stocks-insiders-are-selling"> Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling</a>

Crude Oil Moves Higher; Exelon Earnings Top Estimates

Seaport Global analyst Glenn Chin maintained a Buy rating on Gentherm (THRM – Research Report) today and set a price target of $68.00. The company'...

Gentherm (THRM) Gets a Buy from Seaport Global

Catalyst Watch: Disney earnings, Costco sales update, MicroStrategy split, and eyes on AI patents

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Gentherm (THRM – Research Report), Camping ...

Analysts' Opinions Are Mixed on These Consumer Cyclical Stocks: Gentherm (THRM), Camping World Holdings (CWH) and Yum! Brands (YUM)

Gentherm (THRM) has provided an update. Matteo Anversa has announced his voluntary departure from Gentherm Incorporated as the Executive Vice Presi...

Gentherm CFO Matteo Anversa Plans Departure for New Role

Gentherm announces departure of its CFO

Dorman Products: Significant Bottom-Line Growth Turns Into Favorable Risk/Reward Prospect

Gentherm (THRM) has provided an announcement. Gentherm Incorporated's CFO, Matteo Anversa, will step down on September 1, 2024, to take on a new op...

Gentherm Announces CFO Transition and Interim Successor

Warning: THRM is at high risk of performing badly

JPMorgan upgraded Gentherm (THRM) to Neutral from Underweight with an unchanged price target of $56. The firm cites "incremental attraction" to the...

Gentherm upgraded to Neutral from Underweight at JPMorgan

Craig-Hallum analyst Ryan Sigdahl maintained a Buy rating on Gentherm (THRM – Research Report) today. The company's shares closed last Friday at $4...

Craig-Hallum Keeps Their Buy Rating on Gentherm (THRM)

ABNB

ACCD

AMCX

AMGN

ANET

APTV

CCOI

CELH

CHKP

CLOV

COST

CPNG

CPRI

CRWD

DAVE

DDOG

DORM

ENVA

EXPE

FIVE

FSLY

FTNT

FWRD

GILD

GOOG

HESM

HTLF

ISPO

LCII

LIDR

LUMN

MNST

MSFT

MSTR

PARAA

SHOP

SILK

SKYW

SMCI

TTWO

UBER

UMBF

VZIO

WKME

WULF

Press Releases

Gentherm Receives First Production Vehicle Award for its Puls.A™ Technology

Gentherm Announces New Stock Repurchase Authorization

Contracts

Cognizant and Gentherm Sign Agreement for Strategic Product Engineering Services and Development of a New Delivery Center

Gentherm Named 2024 Top North American Supplier by Honda

Gentherm Announces Date for 2024 Second Quarter Results News Release and Conference Call

Gentherm to Participate in J.P. Morgan Auto Conference

Gentherm Reports 2024 Second Quarter Results

Gentherm Announces Departure of its Chief Financial Officer

Gentherm Announces Date for 2024 Third Quarter Results News Release and Conference Call

Gentherm to Participate in the 2024 Baird Global Industrial Conference

Adient

Autoliv

Aptiv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Dana

Dorman Prods

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Hldg

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Comments

Gentherm

Gentherm (THRM) Opciones

Gentherm (NASDAQ:THRM) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL